Sandoz Lifted By Growth In Europe And Biosimilars
First-Half Sales Of Biosimilars Top A Billion Dollars For Sandoz After Double-Digit Increase
Double-digit growth in the Europe region and in its biosimilars business helped to push up sales for Sandoz in the second quarter and first half of 2023.
